Addressing the obesity challenge in plastic surgery – the role of liraglutide

Stáhnout PDF

Autoři: K. Staněk ^1,2; Richard Billich ³ ; O. Měšťák ¹
Působiště autorů: Department of Plastic Surgery, University Hospital Bulovka and First Faculty of Medicine, Charles University, Prague, Czech Republic ¹; Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA ²; SANUS Sanatorium, Hradec Kralové, Czech Republic ³
Vyšlo v časopise: ACTA CHIRURGIAE PLASTICAE, 65, 2, 2023, pp. 86
Kategorie: Dopis editorovi
doi: https://doi.org/10.48095/ccachp202386

Zdroje

1. Bigarella LG., Ballardin AC., Couto LS., et al. The impact of obesity on plastic surgery outcomes: a systematic review and meta-analysis. Aesthet Surg J. 2022, 42(7): 795–807.

2. Tak YJ., Lee SY. Long-term efficacy and safety of anti-obesity treatment: where do we stand? Curr Obes Rep. 2021, 10(1): 14–30.

3. Astrup A., Rossner S., Van Gaal L., et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 2009, 374(9701): 1606–1616.

4. Pi-Sunyer X., Astrup A., Fujioka K., et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015, 373(1): 11–22.

5. Blackman A., Foster GD., Zammit G., et al. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. Int J Obes (Lond). 2016, 40(8): 1310–1319.